F4 FundFund
TeamPortfolioRaiseEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investorsSimilar Firms

3i Partners

3ipartners.vc · Los Altos, CA

Investment thesis

India's next development chapter will be driven by deep tech companies solving complex health, safety and efficiency problems. Back visionary technical founders with unique IP and global ambition at pre-seed and seed, and help them reach global capital and markets.

$150K – $1M
Check Size
01Investment Thesis

India's next development chapter will be driven by deep tech companies solving complex health, safety and efficiency problems. Back visionary technical founders with unique IP and global ambition at pre-seed and seed, and help them reach global capital and markets.

02Investment Team
KG
Kumar Ganapathy
General Partner
RC
Ravikrishna Cherukuri
General Partner
ST
Subodh Toprani
General Partner
AK
AGK Karunakaran
General Partner
SC
Shalini Chhabra
Venture Partner
RM
Ravi Mistry
Venture Partner
SR
Subha Rajana
Venture Partner
PC
Patrick Cyril
Venture Partner
KA
Kavya Agarwal
Vice President
ST
Shivank Tripathi
Associate
03F4 Research Brief

3i Partners Research

Investment Thesis

3i Partners is an early-stage deep tech venture fund for Indian founders, started by Indian-origin technology entrepreneurs and executives based in Silicon Valley. The firm's stated belief is that India's next development chapter will be driven by technology companies solving complex problems in health, safety and efficiency, and that transformational companies from India can have global reach. Its tagline is "Fueling Disruptive Innovations from India to the world." The firm was founded in 2020 and says its team brings more than 150 years of combined experience, 25+ startups founded, 13+ founders, $1B+ raised and $5B+ in exits.

The firm looks for three things: a visionary founding team with deep technical expertise, companies building for large markets with a global perspective and scalable business models, and distinctive intellectual property that creates a durable moat. It invests "at the edge of what many think is feasible or viable today."

Sector Focus

The firm names three focus areas.

  • Tech Bio: screening and diagnostic tools, AI-based drug development, synthetic biology and bio-engineering platforms, precision therapeutics and cell and gene therapy, RNA and protein technologies, CRISPR and gene editing, digital health and EHRs, biomaterials and regenerative medicine, neurotechnology and brain-computer interfaces.
  • Frontier Tech: AI and machine learning, robotics and automation, advanced materials and nanotechnology, semiconductors, next-generation and quantum compute, aerospace and space.
  • Climate Tech: renewable energy, carbon capture and storage, energy storage and grid technologies, sustainable materials, water and waste management, sustainable agriculture and precision agriculture.

The portfolio shows the mix: underwater inspection robots (Planys), multi-e-beam lithography, PCB-based axial flux motors, cell-free biomanufacturing, non-viral gene delivery, NK-cell immunotherapy, PFAS-free membranes, molecular filtration, diagnostics, dialysis and emergency medical services, plus several circular-economy and social-impact companies.

Stage Focus

Pre-seed and seed. The firm states it supports follow-on fundraising, technology development, talent acquisition and global expansion after the first check.

Check Size

$150K to $1M per startup (about ₹1 to ₹8 crore), targeting a 5% to 15% ownership stake.

Lead Tendency

Not stated on the site. Its portfolio news shows 3i Partners as an early backer in rounds later led by others (for example Planys, whose April 2024 and December 2025 rounds were led by Ashish Kacholia), so lead tendency is recorded as unknown.

Recent Activity

The firm's news page lists portfolio milestones rather than its own new investments: Planys Technologies raised ₹43 crore in April 2024 and ₹100 crore in December 2025 and launched a joint venture in Qatar; Medulance closed a ₹24.57 crore Series A in April 2024; ReCircle launched its textile waste vertical in June 2024; Tan90 raised ₹11.3 crore; Exposome raised funding for water and air purification; Aikium was covered for its AI-driven mRNA engine. Third-party trackers show about 21 portfolio companies and only one new investment in the last twelve months, which suggests the pace of new deployment is slow. Fund size and fund status are not disclosed on the site.

Portfolio Highlights

  • Planys Technologies (underwater inspection robotics, Forbes 30 Under 30 feature)
  • Medulance (emergency ambulance services)
  • Padcare (sanitary waste recycling, appeared on Shark Tank India)
  • ReCircle (plastic and EPR credits platform)
  • Tan90 (phase-change-material cooling)
  • Hemex Health (malaria and sickle cell diagnostics)
  • Zumutor Biologics (NK-cell-targeted immunotherapy, lead candidate in Phase 1)
  • Aikium (GPCR therapeutic design platform)
  • Haqdarshak, Hasiru Dala, Centa (social-impact companies)

Team

  • Kumar Ganapathy, General Partner (founder and Managing Director per podcast bio)
  • Ravikrishna Cherukuri, General Partner
  • Subodh Toprani, General Partner
  • AGK Karunakaran, General Partner
  • Shalini Chhabra, Ravi Mistry, Subha Rajana, Patrick Cyril, Venture Partners
  • Kavya Agarwal, Vice President
  • Arvind Kannan, CTO; Sukesh Khandelwal, CFO
  • Shivank Tripathi, Associate; Harsh Tiwari and Aditi Shimpi, Analysts

Decision Process

Not disclosed. The firm has four general partners, so it is presumably a partnership. Inbound pitches are accepted through a Pitch to Us form on the site.

Founder Preferences

Deep technical founders with proprietary IP, ambition for global markets, and a willingness to use hands-on strategic help from founders who have scaled companies in the US. Portfolio founders describe the firm as engaged on strategy and a useful sounding board.

Geographic Focus

India-based startups building for the world. The firm is headquartered in Los Altos, California, with offices in Bangalore (Whitefield) and Mumbai. Contact: [email protected].

Gaps

Fund size, AUM, vintage of current fund and lead tendency are not published. Portfolio stages and investment dates are not given on the site, so none are recorded.

04Selected Portfolio
Aerospace & Defense
Airbuddy Aerospace
Biotech & Life Sciences
Cellarim Labs·CyGenica·Zumutor Biologics·Aikium·D-Nome
Climate & Sustainability
ReCircle·PadCare Labs·Urdhvam·Hasiru Dala·Exposome
Consumer Apps & Social
CENTA
Energy & Power
Vimäno
Fintech & Payments
Haqdarshak
Healthcare & Digital Health
Litemed·Medulance·VitusCare·Hemex Health
Logistics & Supply Chain
Tan90 Thermal Solutions
Mobility & Transportation
Ergon
Robotics & Automation
Planys Technologies
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (6) →
Portfolio company Aikium was profiled for its AI-driven mRNA engine targeting disordered proteins.
MILESTONE·biopharminternational.com
Added recently
Portfolio company Tan90 raised ₹11.3 crore in a round led by Blue Ashva Capital.
MILESTONE·economictimes.indiatimes.com
Added recently
Portfolio company Planys Technologies raised ₹100 crore to scale underwater robotics globally and launch a defence arm.
MILESTONE·marcamoney.com
DEC 2025
Portfolio company ReCircle launched its textile waste management vertical, Project Extra Life.
MILESTONE·business-standard.com
JUN 6, 2024
Portfolio company Medulance closed a ₹24.57 crore Series A.
MILESTONE·businesstoday.in
APR 18, 2024
06Frequent co-investors
CV
Colossa Ventures
Both backed 2 of the same companies
CENTA, Exposome
Find the investors for your round→
07Similar Firms
AC
Avaana Capital
$120K – $2M · Seed · Series A
→
CV
Creative Ventures
$1M – $3M · Pre-Seed · Seed
→
GL
GVFL Limited
$30K – $2.4M · Pre-Seed · Seed
→
DC
Divergent Capital
$250K – $1M · Pre-Seed · Seed
→
UI
Unicorn India Ventures
Seed · Series A
→
Quick Reference
Check Size
$150K – $1M
Stages
Pre-Seed · Seed
Decision
Partnership
Location
Los Altos, CA
Sector Focus
Biotech & Life SciencesSemiconductors & HardwareRobotics & AutomationClimate & SustainabilityEnergy & PowerHealthcare & Digital Health
Models
Deep Tech
Technology
Tech BioFrontier TechClimate Tech
See all Biotech & Life Sciences investors →See all Semiconductors & Hardware investors →See all Robotics & Automation investors →
Visit 3ipartners.vc ↗

See how 3i Partners matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Biotech & Life SciencesSemiconductors & HardwareRobotics & AutomationClimate & SustainabilityEnergy & PowerHealthcare & Digital Health

See how 3i Partners matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched October 23, 2026F4 Research Engine